Showing results (71-80 of 377) with videos related to
Sort By:
Pageof 38
British Journal of Cancer|March 30, 2016
Breast cancer risk feedback to women in the UK NHS breast screening populationD Gareth R Evans, Louise S Donnelly, Elaine F Harkness, et al.Best Practice & Research. Clinical Endocrinology & Metabolism|December 23, 2003
The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancerSacha J Howell, Stephen R D Johnston, Anthony HowellJournal of Medical Genetics|October 26, 2010
Uptake of breast cancer prevention and screening trialsD Gareth Evans, Michelle Harvie, Nigel Bundred, et al.Journal of Medical Genetics|July 24, 2014
Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studiesD Gareth Evans, Elaine Harkness, Fiona Lalloo, et al.Journal of Neurosurgery|January 5, 2008
What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?D Gareth R Evans, Richard T Ramsden, Andrew Shenton, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 1, 2011
Empirical development of improved diagnostic criteria for neurofibromatosis 2Michael E Baser, Jan M Friedman, Harry Joe, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapySaba Sharif, Rosalie Ferner, Jillian M Birch, et al.Psycho-Oncology|January 28, 2004
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot studyValerie Jenkins, Valerie Shilling, Lesley Fallowfield, et al.Cell Proliferation|October 3, 2003
Regulation of human breast epithelial stem cellsRobert B Clarke, Elizabeth Anderson, Anthony Howell, et al.Breast (Edinburgh, Scotland)|May 15, 2022
Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort studyDavid P French, Lorna McWilliams, Anthony Howell, et al.Pageof 38